Suppr超能文献

中心静脉置管对 incident hemodialysis vascular access 的影响:一项国际性登记研究的分析。

Center-Effect of Incident Hemodialysis Vascular Access Use: Analysis of a Bi-national Registry.

机构信息

Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.

Australasian Kidney Trials Network, Faculty of Medicine, University of Queensland, Brisbane, Australia.

出版信息

Kidney360. 2021 Feb 9;2(4):674-683. doi: 10.34067/KID.0005742020. eCollection 2021 Apr 29.

Abstract

BACKGROUND

Commencing hemodialysis (HD) with an arteriovenous access is associated with superior patient outcomes compared with a catheter, but the majority of patients in Australia and New Zealand initiate HD with a central venous catheter. This study examined patient and center factors associated with arteriovenous fistula/graft access use at HD commencement.

METHODS

We included all adult patients starting chronic HD in Australia and New Zealand between 2004 and 2015. Access type at HD initiation was analyzed using logistic regression. Patient-level factors included sex, age, race, body mass index (BMI), smoking status, primary kidney disease, late nephrologist referral, comorbidities, and prior RRT. Center-level factors included size; transplant capability; home HD proportion; incident peritoneal dialysis (average number of patients commencing RRT with peritoneal dialysis per year); mean weekly HD hours; average blood flow; and achievement of phosphate, hemoglobin, and weekly Kt/V targets. The study included 27,123 patients from 61 centers.

RESULTS

Arteriovenous access use at HD commencement varied four-fold from 15% to 62% (median 39%) across centers. Incident arteriovenous access use was more likely in patients aged 51-72 years, males, and patients with a BMI of >25 kg/m and polycystic kidney disease; but use was less likely in patients with a BMI of <18.5 kg/m, late nephrologist referral, diabetes mellitus, cardiovascular disease, chronic lung disease, and prior RRT. Starting HD with an arteriovenous access was less likely in centers with the highest proportion of home HD, and no center factor was associated with higher arteriovenous access use. Adjustment for center-level characteristics resulted in a 25% reduction in observed intercenter variability of arteriovenous access use at HD initiation compared with the model adjusted for only patient-level characteristics.

CONCLUSIONS

This study identified several patient and center factors associated with incident HD access use, yet these factors did not fully explain the substantial variability in arteriovenous access use across centers.

摘要

背景

与中心静脉导管相比,动静脉通路开始血液透析(HD)与患者预后更好相关,但澳大利亚和新西兰的大多数患者开始 HD 时使用的是中央静脉导管。本研究探讨了与 HD 起始时动静脉瘘/移植物使用相关的患者和中心因素。

方法

我们纳入了 2004 年至 2015 年期间在澳大利亚和新西兰开始慢性 HD 的所有成年患者。使用逻辑回归分析 HD 起始时的通路类型。患者水平的因素包括性别、年龄、种族、体重指数(BMI)、吸烟状况、原发性肾脏疾病、晚期肾病医生转诊、合并症和既往肾脏替代治疗(RRT)。中心水平的因素包括规模、移植能力、家庭 HD 比例、腹膜透析发生率(每年开始 RRT 的患者中腹膜透析的平均人数)、每周平均 HD 小时数、平均血流、以及磷酸盐、血红蛋白和每周 Kt/V 目标的达标情况。该研究纳入了来自 61 个中心的 27123 名患者。

结果

HD 起始时动静脉通路的使用在中心之间差异高达 4 倍,从 15%到 62%(中位数 39%)。51-72 岁的患者、男性患者和 BMI>25kg/m2和多囊肾病患者更有可能使用动静脉通路;但 BMI<18.5kg/m2、晚期肾病医生转诊、糖尿病、心血管疾病、慢性肺病和既往 RRT 的患者使用动静脉通路的可能性较低。在家庭 HD 比例最高的中心开始 HD 时,使用动静脉通路的可能性较低,而且没有中心因素与更高的动静脉通路使用率相关。与仅调整患者水平特征的模型相比,调整中心水平特征后,HD 起始时动静脉通路使用的观察到的中心间变异性降低了 25%。

结论

本研究确定了与 HD 接入使用率相关的几个患者和中心因素,但这些因素并不能完全解释中心之间动静脉接入使用率的巨大差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbec/8791318/378b92c1de66/KID.0005742020absf1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验